Thus, we analyzed the correlations of INHBA expression with immune infiltration levels in BRCA (breast invasive carcinoma) and the subtypes (BRCA-Basal, BRCA-Her2, BRCA-LumA, and BRCA-LumB) by TIMER2.0. The gene discussed is ERBB2; the disease is invasive breast carcinoma.